FY2026 EPS Forecast for Cardinal Health Boosted by Analyst

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Analysts at Leerink Partnrs lifted their FY2026 earnings per share (EPS) estimates for Cardinal Health in a note issued to investors on Tuesday, June 3rd. Leerink Partnrs analyst M. Cherny now expects that the company will earn $9.13 per share for the year, up from their prior forecast of $9.11. The consensus estimate for Cardinal Health's current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health's FY2027 earnings at $10.01 EPS and FY2028 earnings at $10.97 EPS.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The firm had revenue of $54.88 billion for the quarter, compared to analysts' expectations of $55.33 billion. During the same period in the previous year, the business earned $2.08 earnings per share. Cardinal Health's revenue for the quarter was up .0% compared to the same quarter last year.

CAH has been the topic of several other research reports. Robert W. Baird upped their price target on Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Wells Fargo & Company upgraded Cardinal Health from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $136.00 to $179.00 in a report on Tuesday. Mizuho boosted their target price on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Citigroup reiterated a "neutral" rating on shares of Cardinal Health in a research report on Thursday, May 1st. Finally, Morgan Stanley lifted their price target on Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $149.50.

Cardinal Health Trading Down 0.1%

CAH stock traded down $0.22 on Wednesday, hitting $153.85. 2,257,272 shares of the company's stock traded hands, compared to its average volume of 2,216,547. The stock has a market cap of $36.72 billion, a price-to-earnings ratio of 28.70, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health has a 1-year low of $93.17 and a 1-year high of $157.82. The stock has a fifty day moving average of $142.85 and a 200-day moving average of $130.95.

Hedge Funds Weigh In On Cardinal Health

Several institutional investors and hedge funds have recently modified their holdings of CAH. Mirae Asset Global Investments Co. Ltd. increased its position in Cardinal Health by 35.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock worth $3,871,000 after purchasing an additional 8,471 shares during the last quarter. Consolidated Planning Corp grew its stake in shares of Cardinal Health by 40.0% in the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock valued at $1,056,000 after buying an additional 2,552 shares in the last quarter. Flputnam Investment Management Co. grew its stake in shares of Cardinal Health by 1.8% in the 4th quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock valued at $21,358,000 after buying an additional 3,148 shares in the last quarter. Huntington National Bank increased its holdings in Cardinal Health by 1.2% in the fourth quarter. Huntington National Bank now owns 10,920 shares of the company's stock worth $1,292,000 after buying an additional 128 shares during the last quarter. Finally, JSF Financial LLC bought a new position in Cardinal Health during the fourth quarter valued at approximately $967,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.33%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is 31.83%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.